{"id":4230,"date":"2019-07-04T14:13:42","date_gmt":"2019-07-04T12:13:42","guid":{"rendered":"https:\/\/ww2.omceoge.it\/?page_id=4230"},"modified":"2019-07-04T14:13:42","modified_gmt":"2019-07-04T12:13:42","slug":"4230-nota-aifa-adenuric-aumento-del-rischio-di-morte-cardiovascolare-e-mortalita-per-qualsiasi-causa-nei-pazienti-trattati-con-febuxostat-nell-ambito-dello-studio-cares","status":"publish","type":"post","link":"https:\/\/www.omceoge.it\/home9\/item\/4230-nota-aifa-adenuric-aumento-del-rischio-di-morte-cardiovascolare-e-mortalita-per-qualsiasi-causa-nei-pazienti-trattati-con-febuxostat-nell-ambito-dello-studio-cares\/","title":{"rendered":"Nota AIFA &#8211; Adenuric aumento del rischio di morte cardiovascolare e mortalit\u00e0 per qualsiasi causa nei pazienti trattati con Febuxostat nell&#8217;ambito dello studio CARES"},"content":{"rendered":"<p>Pubblichiamo la Comunicazione FNOMCeO n. 97 con la quale viene divulgata la nota AIFA relativa a Adenuric<\/p>\n<hr class=\"readMore\">\n<div class=\"div_pdf_js\"><a class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/NotaZAIFA_Adenuric.pdf\"><span class=\"span_pdf_icon\">PDF<img decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Comunicazione FNOMCEO<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pubblichiamo la Comunicazione FNOMCeO n. 97 con la quale viene divulgata la nota AIFA relativa a Adenuric<\/p>\n","protected":false},"author":563,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[],"class_list":["post-4230","post","type-post","status-publish","format-standard","hentry","category-notizie-dall-aifa"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/4230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/users\/563"}],"replies":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/comments?post=4230"}],"version-history":[{"count":0,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/4230\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/media?parent=4230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/categories?post=4230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/tags?post=4230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}